 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/15/2019 |
$6.65 |
$6.65 |
$6.31 |
$6.43 |
48.80K | | 02/19/2019 |
$6.45 |
$6.51 |
$6.45 |
$6.47 |
5.60K | | 02/20/2019 |
$6.48 |
$6.51 |
$6.43 |
$6.43 |
8.40K | | 02/21/2019 |
$6.50 |
$6.51 |
$6.47 |
$6.49 |
7.70K | | 02/22/2019 |
$6.49 |
$6.58 |
$6.25 |
$6.47 |
8.20K |
|
|
| Sinovac Biotech is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Co.'s products include: Healive, an inactivated hepatitis A vaccine; Bilive, a combined inactivated hepatitis A and B vaccine; Anflu, a vaccine against influenza; Panflu, a vaccine against the H5N1 influenza virus; Split Viron Pandemic Influenza Vaccine, an influenza vaccine; Panflu.1, a vaccine against the influenza A H1N1 virus; Mumps Vaccine; Inlive, a treatment for HFMD; and Varicella Vaccine, a vaccine for disease caused by the varicella-zoster virus. | |
|
Sinovac Biotech (SVA) has the following price history information. Looking back at SVA historical stock prices for the last five trading days, on February 15, 2019, SVA opened at $6.65, traded as high as $6.65 and as low as $6.31, and closed at $6.43. Trading volume was a total of 48.80K shares. On February 19, 2019, SVA opened at $6.45, traded as high as $6.51 and as low as $6.45, and closed at $6.47. Trading volume was a total of 5.60K shares. On February 20, 2019, SVA opened at $6.48, traded as high as $6.51 and as low as $6.43, and closed at $6.43. Trading volume was a total of 8.40K shares. On February 21, 2019, SVA opened at $6.50, traded as high as $6.51 and as low as $6.47, and closed at $6.49. Trading volume was a total of 7.70K shares. On February 22, 2019, SVA opened at $6.49, traded as high as $6.58 and as low as $6.25, and closed at $6.47. Trading volume was a total of 8.20K shares.
SVA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Sinovac Biotech shares, starting with a $10,000 purchase of SVA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/27/2015 |
|
| End date: |
02/22/2019 |
|
| Start price/share: |
$4.83 |
|
| End price/share: |
$6.47 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
33.95% |
|
| Average Annual Total Return: |
7.44% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$13,395.82 |
|
| Years: |
4.07 |
|
|
|
| Date |
Close |
| 02/15/2019 | $6.43 | | 02/19/2019 | $6.47 | | 02/20/2019 | $6.43 | | 02/21/2019 | $6.49 | | 02/22/2019 | $6.47 |
|
|
Free SVA Email Alerts:
